Select Medical Holdings Co. (NYSE: SEM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Select Medical Holdings Co. (NYSE: SEM) had its price target lowered by analysts at UBS Group AG from $40.00 to $21.00. They now have a "neutral" rating on the stock.
Select Medical Holdings Co. (NYSE: SEM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
CLR Neurosthenics® launches neurophysiological assessment platform to help prevent sports injuries, optimize performance and improve rehabilitation [Yahoo! Finance]
Select Medical Holdings Co. (NYSE: SEM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.